Prospective observational registry for cystinuria patients on Thiola EC therapy
Brief description of study
The purpose of this research study is to follow patients on Thiola EC for two years and collect cystinuria related treatment information in order to see how they are doing. Thiola EC is Food and Drug Administration (FDA) approved for the treatment of cystinuria. This study is not testing Thiola EC.
Clinical Study Identifier: s20-00331
ClinicalTrials.gov Identifier: NCT05048563
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
